SCHEDULE: Biomea Fusion: CVI Investments Maintains 9.9% Stake
Schedule 13G Amendment
CVI Investments, Inc. and Heights Capital Management, Inc. disclose a continued 9.9% beneficial ownership in Biomea Fusion, Inc. via warrants.
Summary
- CVI Investments, Inc. and its investment manager, Heights Capital Management, Inc., collectively report beneficial ownership of 7,847,232 shares of Biomea Fusion, Inc. common stock.
- This ownership represents 9.9% of Biomea Fusion, Inc.'s outstanding common stock.
- The reported shares are issuable upon the exercise of warrants to purchase shares.
- The warrants are structured with a limitation, preventing exercise if it would result in beneficial ownership exceeding 9.99% of the company's shares.
- Biomea Fusion, Inc. had 70,703,639 shares outstanding as of October 31, 2025, as reported in its Form 10-Q filed on November 4, 2025.
- This filing is an Amendment No. 2 to a Schedule 13G, indicating an update to previously reported ownership information.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive disclosure. While a 13G is a factual report, the continued significant stake (9.9%) by an institutional investor, even if passive, can be interpreted as a sustained vote of confidence in Biomea Fusion, Inc.
Positives
- NA
Negatives
- NA
Risks
- NA
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding Biomea Fusion, Inc.'s future performance or operations, focusing solely on beneficial ownership disclosure.
Management Comments
- Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc., certified that the securities were not acquired and are not held for the purpose of changing or influencing the control of the issuer, nor in connection with any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.
Industry Context
StockSavvy.ai notes that institutional ownership disclosures like this Schedule 13G provide transparency into significant stakes held by investment firms. For a biotechnology company like Biomea Fusion, Inc., a substantial stake held by an investment manager like Heights Capital Management, Inc. can signal institutional confidence, although the passive nature of a 13G filing indicates no intent to influence control. This type of filing is a routine disclosure for investors crossing the 5% ownership threshold.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership, potentially signaling confidence from a major investor.
- Company Management: Awareness of a large, passive institutional holder, though without intent to influence control.
Key Dates
| Date | Description |
|---|---|
| 2025-10-31 | Date as of which Biomea Fusion, Inc. reported 70,703,639 shares outstanding in its Form 10-Q. |
| 2025-11-04 | Date Biomea Fusion, Inc. filed its Quarterly Report on Form 10-Q. |
| 2025-12-31 | Date of event which requires the filing of this statement (beneficial ownership reporting date). |
| 2026-02-10 | Date the Schedule 13G Amendment No. 2 was signed and filed. |
Keywords
Biomea Fusion, CVI Investments, Heights Capital Management, Beneficial Ownership, Schedule 13G, Warrants, Institutional Investment, Biotechnology, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.